Table A1.
Characteristics of the patients with identified pathogens analysed according to AMR.
| AMR | Value (Nr., %/Mean ± SD/Median (IQR)) | p | |
|---|---|---|---|
| Absent (n = 17) | Present (n = 31) | ||
| Age | 55.71 ± 16.67 | 62.52 ± 16.02 | 0.172 * |
| Gender (male) | 7 (41.2%) | 14 (45.2%) | 1.000 ** |
| Septic shock | 5 (29.4%) | 11 (35.5%) | 0.757 ** |
| WBC | 14,560 (12,060–18,370) | 15,650 (14,210–19,540) | 0.456 *** |
| CRP | 98 (66–190.5) | 116 (82–211) | 0.264 *** |
| Procalcitonin | 2.73 (0.54–6.34) | 3.12 (1.3–9.18) | 0.301 *** |
| ASA grading | |||
| I | 1 (5.9%) | 1 (3.2%) | 0.360 ** |
| II | 12 (70.6%) | 14 (45.2%) | |
| III | 3 (17.6%) | 7 (22.6%) | |
| IV | 1 (5.9%) | 6 (19.4%) | |
| V | 0 (0%) | 3 (9.7%) | |
| Comorbidities | 6 (35.3%) | 16 (51.6%) | 0.368 ** |
| Cardiovascular disease | 6 (35.3%) | 16 (51.6%) | 0.368 ** |
| Diabetes mellitus | 0 (0%) | 1 (3.2%) | 1.000 ** |
| Hinchey class | |||
| IIA | 2 (11.8%) | 5 (16.1%) | 0.004 ** |
| IIB | 13 (76.5%) | 8 (25.8%) | |
| III | 1 (5.9%) | 14 (45.2%) | |
| IV | 1 (5.9%) | 4 (12.9%) | |
| Source control procedure | |||
| Laparoscopic drainage | 7 (41.2%) | 9 (29%) | 0.159 ** |
| Laparoscopic resection + anastomosis | 4 (23.5%) | 5 (16.1%) | |
| Laparoscopic Hartmann’s procedure | 1 (5.9%) | 5 (16.1%) | |
| Open resection + anastomosis | 2 (11.8%) | 0 (0%) | |
| Open Hartmann’s procedure | 3 (17.6%) | 12 (38.7%) | |
| Multiple pathogens | 3 (17.6%) | 9 (29%) | 0.497 ** |
| ICU admission > 1 day | 5 (29.4%) | 14 (45.2%) | 0.363 ** |
| Length of stay | |||
| <7 days | 6 (35.3%) | 9 (29%) | 0.273 ** |
| 7–10 days | 10 (58.8%) | 14 (45.2%) | |
| >10 days | 1 (5.9%) | 8 (25.8%) | |
| Adequate empiric AB therapy | 17 (100%) | 19 (61.3%) | 0.004 ** |
| Mortality | 0 (0%) | 3 (9.7%) | 0.543 ** |
* Student T-Test, ** Fisher’s Exact Test, *** Mann–Whitney U Test.